Jonathan Yong
Stock Analyst at UBS
(2.61)
# 2,235
Out of 4,981 analysts
97
Total ratings
60.38%
Success rate
11.15%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $4.00 | +25.00% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $3.06 | -1.96% | 4 | Aug 6, 2025 | |
| OSCR Oscar Health | Downgrades: Sell | $15 → $11 | $19.33 | -43.09% | 8 | Jul 15, 2025 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $26.63 | -6.10% | 2 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.87 | +52.48% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.19 | +90.93% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $12.56 | +107.01% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $55.50 | -74.77% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $69.01 | +39.11% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $12.51 | +155.80% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $18.25 | +475.34% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $126.05 | -36.53% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $277.95 | -16.89% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.68 | +251.56% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $152.24 | -34.31% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $711.42 | -36.75% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $4.15 | +189.51% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $6.64 | +954.22% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $16.02 | +6.15% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $180.88 | +93.50% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $21.73 | +337.18% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $4.95 | +71.72% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $22.79 | +79.90% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $5.34 | +218.35% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.94 | +189.12% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $80.09 | +6.13% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $182.91 | -20.18% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $33.26 | +218.70% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $191.72 | -18.11% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $302.76 | +21.55% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $276.44 | +129.71% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $74.98 | +56.04% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $16.64 | +80.29% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $405.13 | -26.44% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $192.82 | -50.73% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $352.51 | +40.42% | 1 | Oct 15, 2021 |
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.00
Upside: +25.00%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $3.06
Upside: -1.96%
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15 → $11
Current: $19.33
Upside: -43.09%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $26.63
Upside: -6.10%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.87
Upside: +52.48%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.19
Upside: +90.93%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $12.56
Upside: +107.01%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $55.50
Upside: -74.77%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $69.01
Upside: +39.11%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $12.51
Upside: +155.80%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $18.25
Upside: +475.34%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $126.05
Upside: -36.53%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $277.95
Upside: -16.89%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.68
Upside: +251.56%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $152.24
Upside: -34.31%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $711.42
Upside: -36.75%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $4.15
Upside: +189.51%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $6.64
Upside: +954.22%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $16.02
Upside: +6.15%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $180.88
Upside: +93.50%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $21.73
Upside: +337.18%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $4.95
Upside: +71.72%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.79
Upside: +79.90%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $5.34
Upside: +218.35%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.94
Upside: +189.12%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $80.09
Upside: +6.13%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $182.91
Upside: -20.18%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $33.26
Upside: +218.70%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $191.72
Upside: -18.11%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $302.76
Upside: +21.55%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $276.44
Upside: +129.71%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $74.98
Upside: +56.04%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $16.64
Upside: +80.29%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $405.13
Upside: -26.44%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $192.82
Upside: -50.73%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $352.51
Upside: +40.42%